Global Endocrinology and Metabolism market is projected to reach US$ 173930 million by 2030.

Summary: Global Endocrinology and Metabolism Market, valued at $77.73 billion in 2023, is projected to grow to $197.56 billion by 2033, at a CAGR of 12.1%. This growth is driven by the rising prevalence of endocrine diseases like diabetes, obesity, and thyroid disorders, along with an aging population, sedentary lifestyles, and poor eating habits. The market includes products for diagnostic tests, medications, and treatments targeting hormonal and metabolic imbalances. Key market segments include diabetes drugs, HGH treatments, and thyroid hormone therapies, with demand spread across hospital pharmacies, retail pharmacies, and online pharmacies. Major players in the market include Eli Lilly, Abbott Laboratories, and Hoffmann-La Roche. The market is seeing increasing investment in innovation to meet the growing healthcare needs of patients worldwide.
Click for Free Sample Report with All Related Graphs & Charts: https://prospectresearchreports.com/report/423703?type=request_sample